Discussion 7

Discussion 7

 Stanford University medical  researchers conducted a study on the correlation between the use of  fertility drugs and ovarian cancer.  Their study, published in the  American Journal of Epidemiology, concludes that the use of the  fertility drugs, Pergonal and Serophene, may increase the risk of  ovarian cancer by three times.  The lead author of the studies,  Professor Alice Whittemore, stated, “Our finding in regard to fertility  drugs is by no means certain.  It is based on very small numbers and is  really very tenuous.”

FDA  Commissioner David Kessler would like the infertility drug  manufacturers to disclose the study findings and offer a warning on the  drug packages.  He notes, “Even though the epidemiology study is still  preliminary, women have a right to know what is known.  We’re not  looking to make more of this than there is.”

If you were a manufacturer of one of the drugs, would you voluntarily disclose the study information? 

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply